APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Vaccines

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Selected research

Market Structure

Global Swine Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchSwine Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Swine Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Read the full market overview

China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

This report provides an overview of the global Swine Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Vaccines Segment by Company

Merck

Boehringer Ingelheim

Jinyu Bio-Technology

CAHIC

Tecon

Zoetis

Ceva

Hile Bio

Chopper Biology

WINSUN

Hipra

Ringpu Biology

ChengDu Tecbond

DHN

CAVAC

Virbac

HVRI

Bioveta

Swine Vaccines Segment by Type

CSF Vaccines

FMD Vaccines

Porcine Circovirus Vaccines

PRRS Vaccines

Others

Swine Vaccines Segment by Application

Government Tender

Market Sales

Swine Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Swine Vaccines Industry Trends Table 2. Swine Vaccines Industry Drivers Table 3. Swine Vaccines Industry Opportunities and Challenges Table 4. Swine Vaccines Industry Restraints Table 5. Global Swine Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Swine Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Swine Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Swine Vaccines Sales Market Share by Manufacturers Table 9. Global Swine Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Swine Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Swine Vaccines Manufacturers, Product Type & Application Table 13. Global Swine Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of CSF Vaccines Table 17. Major Manufacturers of FMD Vaccines Table 18. Major Manufacturers of Porcine Circovirus Vaccines Table 19. Major Manufacturers of PRRS Vaccines Table 20. Major Manufacturers of Others Table 21. Global Swine Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 22. Global Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 23. Global Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 24. Global Swine Vaccines Sales Market Share by Type (2021-2026) Table 25. Global Swine Vaccines Sales Market Share by Type (2027-2032) Table 26. Global Swine Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 27. Global Swine Vaccines Revenue by Type (2021-2026) & (M Doses) Table 28. Global Swine Vaccines Revenue by Type (2027-2032) & (M Doses) Table 29. Global Swine Vaccines Revenue Market Share by Type (2021-2026) Table 30. Global Swine Vaccines Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Government Tender Table 32. Major Manufacturers of Market Sales Table 33. Global Swine Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 34. Global Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 35. Global Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 36. Global Swine Vaccines Sales Market Share by Application (2021-2026) Table 37. Global Swine Vaccines Sales Market Share by Application (2027-2032) Table 38. Global Swine Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 39. Global Swine Vaccines Revenue by Application (2021-2026) & (M Doses) Table 40. Global Swine Vaccines Revenue by Application (2027-2032) & (M Doses) Table 41. Global Swine Vaccines Revenue Market Share by Application (2021-2026) Table 42. Global Swine Vaccines Revenue Market Share by Application (2027-2032) Table 43. Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 44. Global Swine Vaccines Sales by Region (2021-2026) & (M Doses) Table 45. Global Swine Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Swine Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 47. Global Swine Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 49. North America Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 50. North America Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 51. Europe Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 52. Europe Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 53. Europe Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 54. Asia Pacific Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. Asia Pacific Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 56. Asia Pacific Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 57. South America, Middle East and Africa Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 58. South America, Middle East and Africa Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 59. South America, Middle East and Africa Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 60. Global Swine Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Swine Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Swine Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Swine Vaccines Revenue Market Share by Region (2021-2026) Table 64. Global Swine Vaccines Revenue Market Share by Region (2027-2032) Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Merck Swine Vaccines Product Portfolio Table 69. Merck Recent Development Table 70. Boehringer Ingelheim Company Information Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Boehringer Ingelheim Swine Vaccines Product Portfolio Table 74. Boehringer Ingelheim Recent Development Table 75. Jinyu Bio-Technology Company Information Table 76. Jinyu Bio-Technology Business Overview Table 77. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Jinyu Bio-Technology Swine Vaccines Product Portfolio Table 79. Jinyu Bio-Technology Recent Development Table 80. CAHIC Company Information Table 81. CAHIC Business Overview Table 82. CAHIC Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. CAHIC Swine Vaccines Product Portfolio Table 84. CAHIC Recent Development Table 85. Tecon Company Information Table 86. Tecon Business Overview Table 87. Tecon Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Tecon Swine Vaccines Product Portfolio Table 89. Tecon Recent Development Table 90. Zoetis Company Information Table 91. Zoetis Business Overview Table 92. Zoetis Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Zoetis Swine Vaccines Product Portfolio Table 94. Zoetis Recent Development Table 95. Ceva Company Information Table 96. Ceva Business Overview Table 97. Ceva Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Ceva Swine Vaccines Product Portfolio Table 99. Ceva Recent Development Table 100. Hile Bio Company Information Table 101. Hile Bio Business Overview Table 102. Hile Bio Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Hile Bio Swine Vaccines Product Portfolio Table 104. Hile Bio Recent Development Table 105. Chopper Biology Company Information Table 106. Chopper Biology Business Overview Table 107. Chopper Biology Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Chopper Biology Swine Vaccines Product Portfolio Table 109. Chopper Biology Recent Development Table 110. WINSUN Company Information Table 111. WINSUN Business Overview Table 112. WINSUN Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. WINSUN Swine Vaccines Product Portfolio Table 114. WINSUN Recent Development Table 115. Hipra Company Information Table 116. Hipra Business Overview Table 117. Hipra Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Hipra Swine Vaccines Product Portfolio Table 119. Hipra Recent Development Table 120. Ringpu Biology Company Information Table 121. Ringpu Biology Business Overview Table 122. Ringpu Biology Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Ringpu Biology Swine Vaccines Product Portfolio Table 124. Ringpu Biology Recent Development Table 125. ChengDu Tecbond Company Information Table 126. ChengDu Tecbond Business Overview Table 127. ChengDu Tecbond Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. ChengDu Tecbond Swine Vaccines Product Portfolio Table 129. ChengDu Tecbond Recent Development Table 130. DHN Company Information Table 131. DHN Business Overview Table 132. DHN Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. DHN Swine Vaccines Product Portfolio Table 134. DHN Recent Development Table 135. CAVAC Company Information Table 136. CAVAC Business Overview Table 137. CAVAC Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. CAVAC Swine Vaccines Product Portfolio Table 139. CAVAC Recent Development Table 140. Virbac Company Information Table 141. Virbac Business Overview Table 142. Virbac Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Virbac Swine Vaccines Product Portfolio Table 144. Virbac Recent Development Table 145. HVRI Company Information Table 146. HVRI Business Overview Table 147. HVRI Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. HVRI Swine Vaccines Product Portfolio Table 149. HVRI Recent Development Table 150. Bioveta Company Information Table 151. Bioveta Business Overview Table 152. Bioveta Swine Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Bioveta Swine Vaccines Product Portfolio Table 154. Bioveta Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Swine Vaccines Distributors List Table 158. Swine Vaccines Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Swine Vaccines Product Image Figure 2. Global Swine Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Swine Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. CSF Vaccines Image Figure 9. FMD Vaccines Image Figure 10. Porcine Circovirus Vaccines Image Figure 11. PRRS Vaccines Image Figure 12. Others Image Figure 13. Global Swine Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Swine Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Swine Vaccines Sales Market Share by Type (2021-2032) Figure 16. Global Swine Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 17. Global Swine Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Swine Vaccines Revenue Market Share by Type (2021-2032) Figure 19. Government Tender Image Figure 20. Market Sales Image Figure 21. Global Swine Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 22. Global Swine Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Swine Vaccines Sales Market Share by Application (2021-2032) Figure 24. Global Swine Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 25. Global Swine Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Swine Vaccines Revenue Market Share by Application (2021-2032) Figure 27. North America Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. North America Swine Vaccines Sales Market Share by Country (2021-2032) Figure 29. U.S. Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Canada Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Mexico Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. Europe Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. Europe Swine Vaccines Sales Market Share by Country (2021-2032) Figure 34. Germany Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. France Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. U.K. Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Italy Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Netherlands Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Asia Pacific Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Asia Pacific Swine Vaccines Sales Market Share by Country (2021-2032) Figure 41. China Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Japan Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. South Korea Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Southeast Asia Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. India Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. Australia Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. South America, Middle East and Africa Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South America, Middle East and Africa Swine Vaccines Sales Market Share by Country (2021-2032) Figure 49. Brazil Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. South Africa Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Saudi Arabia Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Turkey Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Argentina Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. UAE Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Egypt Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 56. Chile Swine Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 57. Global Swine Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Swine Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Swine Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. North America Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Swine Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Europe Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Swine Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Swine Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Swine Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Swine Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Others
Applications
  • Government Tender
  • Market Sales
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Jinyu Bio-Technology
  • CAHIC
  • Tecon
  • Zoetis
  • Ceva
  • Hile Bio
  • Chopper Biology
  • WINSUN
  • Hipra
  • Ringpu Biology
  • ChengDu Tecbond
  • DHN
  • CAVAC
  • Virbac
  • HVRI
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Swine Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Swine Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Swine Vaccines Market Dynamics
  1. 2.1 Swine Vaccines Industry Trends
  2. 2.2 Swine Vaccines Industry Drivers
  3. 2.3 Swine Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Vaccines Industry Restraints
3 Swine Vaccines Market by Manufacturers
  1. 3.1 Global Swine Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Swine Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Swine Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Swine Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Swine Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Swine Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Vaccines Tier 1, Tier 2, and Tier 3
4 Swine Vaccines Market by Type
  1. 4.1 Swine Vaccines Type Introduction
  2. 4.1.1 CSF Vaccines
  3. 4.1.2 FMD Vaccines
  4. 4.1.3 Porcine Circovirus Vaccines
  5. 4.1.4 PRRS Vaccines
  6. 4.1.5 Others
  7. 4.2 Global Swine Vaccines Sales by Type
  8. 4.2.1 Global Swine Vaccines Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Swine Vaccines Sales by Type (2021-2032)
  10. 4.2.3 Global Swine Vaccines Sales Market Share by Type (2021-2032)
  11. 4.3 Global Swine Vaccines Revenue by Type
  12. 4.3.1 Global Swine Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Swine Vaccines Revenue by Type (2021-2032)
  14. 4.3.3 Global Swine Vaccines Revenue Market Share by Type (2021-2032)
5 Swine Vaccines Market by Application
  1. 5.1 Swine Vaccines Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Swine Vaccines Sales by Application
  5. 5.2.1 Global Swine Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Swine Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Swine Vaccines Revenue by Application
  9. 5.3.1 Global Swine Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Swine Vaccines Revenue Market Share by Application (2021-2032)
6 Global Swine Vaccines Sales by Region
  1. 6.1 Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Swine Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Swine Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Swine Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Swine Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Swine Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Swine Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Swine Vaccines Revenue by Region
  1. 7.1 Global Swine Vaccines Revenue by Region
  2. 7.1.1 Global Swine Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Swine Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Swine Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Swine Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Swine Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Swine Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Swine Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Swine Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Swine Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Swine Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Jinyu Bio-Technology
  14. 8.3.1 Jinyu Bio-Technology Company Information
  15. 8.3.2 Jinyu Bio-Technology Business Overview
  16. 8.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
  18. 8.3.5 Jinyu Bio-Technology Recent Developments
  19. 8.4 CAHIC
  20. 8.4.1 CAHIC Company Information
  21. 8.4.2 CAHIC Business Overview
  22. 8.4.3 CAHIC Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CAHIC Swine Vaccines Product Portfolio
  24. 8.4.5 CAHIC Recent Developments
  25. 8.5 Tecon
  26. 8.5.1 Tecon Company Information
  27. 8.5.2 Tecon Business Overview
  28. 8.5.3 Tecon Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tecon Swine Vaccines Product Portfolio
  30. 8.5.5 Tecon Recent Developments
  31. 8.6 Zoetis
  32. 8.6.1 Zoetis Company Information
  33. 8.6.2 Zoetis Business Overview
  34. 8.6.3 Zoetis Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zoetis Swine Vaccines Product Portfolio
  36. 8.6.5 Zoetis Recent Developments
  37. 8.7 Ceva
  38. 8.7.1 Ceva Company Information
  39. 8.7.2 Ceva Business Overview
  40. 8.7.3 Ceva Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Swine Vaccines Product Portfolio
  42. 8.7.5 Ceva Recent Developments
  43. 8.8 Hile Bio
  44. 8.8.1 Hile Bio Company Information
  45. 8.8.2 Hile Bio Business Overview
  46. 8.8.3 Hile Bio Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hile Bio Swine Vaccines Product Portfolio
  48. 8.8.5 Hile Bio Recent Developments
  49. 8.9 Chopper Biology
  50. 8.9.1 Chopper Biology Company Information
  51. 8.9.2 Chopper Biology Business Overview
  52. 8.9.3 Chopper Biology Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chopper Biology Swine Vaccines Product Portfolio
  54. 8.9.5 Chopper Biology Recent Developments
  55. 8.10 WINSUN
  56. 8.10.1 WINSUN Company Information
  57. 8.10.2 WINSUN Business Overview
  58. 8.10.3 WINSUN Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 WINSUN Swine Vaccines Product Portfolio
  60. 8.10.5 WINSUN Recent Developments
  61. 8.11 Hipra
  62. 8.11.1 Hipra Company Information
  63. 8.11.2 Hipra Business Overview
  64. 8.11.3 Hipra Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hipra Swine Vaccines Product Portfolio
  66. 8.11.5 Hipra Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Swine Vaccines Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 ChengDu Tecbond
  74. 8.13.1 ChengDu Tecbond Company Information
  75. 8.13.2 ChengDu Tecbond Business Overview
  76. 8.13.3 ChengDu Tecbond Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
  78. 8.13.5 ChengDu Tecbond Recent Developments
  79. 8.14 DHN
  80. 8.14.1 DHN Company Information
  81. 8.14.2 DHN Business Overview
  82. 8.14.3 DHN Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 DHN Swine Vaccines Product Portfolio
  84. 8.14.5 DHN Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Swine Vaccines Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 Virbac
  92. 8.16.1 Virbac Company Information
  93. 8.16.2 Virbac Business Overview
  94. 8.16.3 Virbac Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Virbac Swine Vaccines Product Portfolio
  96. 8.16.5 Virbac Recent Developments
  97. 8.17 HVRI
  98. 8.17.1 HVRI Company Information
  99. 8.17.2 HVRI Business Overview
  100. 8.17.3 HVRI Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 HVRI Swine Vaccines Product Portfolio
  102. 8.17.5 HVRI Recent Developments
  103. 8.18 Bioveta
  104. 8.18.1 Bioveta Company Information
  105. 8.18.2 Bioveta Business Overview
  106. 8.18.3 Bioveta Swine Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bioveta Swine Vaccines Product Portfolio
  108. 8.18.5 Bioveta Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Vaccines Value Chain Analysis
  2. 9.1.1 Swine Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Vaccines Production Mode & Process
  6. 9.2 Swine Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Vaccines Distributors
  9. 9.2.3 Swine Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst